|
Ron Taylor is a director of Watson Pharmaceuticals, Inc. (NYSE: WPI) and Red Lion Hotels (NYSE: RLH) and is Chairman of the Board of three privately-held companies: 3E Company, EMN8 Corporation, Asteres, Inc. and Aethon, Inc. Mr. Taylor is also Chairman of the University of California, San Diego Foundation. Beginning in 2002, he also served as chair of the ResMed Foundation, although in connection with his appointment to the Board of Directors, he has resigned from the Foundation board. In 1987, Mr. Taylor founded Pyxis Corporation where he served as Chairman, President, and Chief Executive Officer until its purchase by Cardinal Health, Inc., in 1996. Before founding Pyxis, Mr. Taylor was responsible for the operations and international sales at Hybritech, Inc., for six years. Before joining Hybritech, he served over ten years in management roles at Allergan Pharmaceuticals. Mr. Taylor received a B.A. from the University of Saskatchewan and an M.A. from the University of California, Irvine.
| 